On 28 October 2021, the supervisory committee of Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd. approved the proposed appointment of the current independent Supervisor Mr. Huang Jian ("Mr. Huang") as the chairman of Supervisory Committee, and his proposed term of office will be effected to the expiration date of the seventh session of the Supervisory Committee. Mr. Huang was appointed as an independent Supervisor of the seventh session of the Supervisory Committee on 30 March 2020. Mr. Huang is a professor and doctoral supervisor in the Biochemistry and Molecular Cytology Department of School of Medicine of Shanghai Jiao Tong University and an evaluator of National Natural Science Foundation of China. He conducted his postdoctoral research in the Shanghai Institute of Biochemistry and Cell Biology of Chinese Academy of Sciences and Karolinska Institute in Sweden. He has been working on molecular oncology for a long time and has led multiple national and provincial research projects as chief researcher.